期刊文献+

复方灵芝降糖胶囊对Ⅱ型糖尿病大鼠相关指标的影响 被引量:3

The Effect of Co-lingzhijiangtang Capsule to the Glucose,Lipid and SOD-activity in Blood of Type Ⅱ Melituria Rats
原文传递
导出
摘要 目的:观察复方灵芝降糖胶囊对Ⅱ型糖尿病模型大鼠的作用。方法:以高脂饲料喂饲Wistar大鼠诱发胰岛素抵抗,并以小剂量链尿佐菌素(STZ)ip,诱发Ⅱ型糖尿病。模型大鼠随机分组,ig给药。给药结束后取血进行血糖、甘油三酯(TG)、胆固醇(TC)、超氧化物歧化酶(SOD)检测。结果:与模型组相比,复方灵芝降糖胶囊高,中,低剂量给药1个月后糖尿病大鼠血糖、TG、TC均明显下降,SOD值明显升高,统计学具显著意义。结论:复方灵芝降糖胶囊对大鼠Ⅱ型糖尿病模型有较好的疗效。 Objective:To study the effect of Co-Lingzhi jiangtang Capsule to type Ⅱ melituria rats. Method: To make the model of type Ⅱ melituria rats with feeding hyper-lipid fodder and injecting a small dosage STZ to intraperitoneum. And then the modle rats were divided into 7 groups and administered. After administration the blood samples were taken to determine their blood glucose, TG, TC, and SOD. Results: Compareing to control group, the capsule has obvious effects on lowering blood glucose, TG and TC and enhanceing SOD-activity after administration for 1 month. Conclusion: The Co-Lingzhijiangtang Capsule may be an effective medicine to treat type Ⅱ diabetes mellitus.
出处 《中国实验方剂学杂志》 CAS 北大核心 2009年第1期55-56,共2页 Chinese Journal of Experimental Traditional Medical Formulae
基金 黑龙江省教育厅资助项目(11511366)
关键词 复方灵芝降糖胶囊 Ⅱ型糖尿病 血糖 血脂 超氧化物歧化酶 Co-lingzhijiangtang Capsule Ⅱ type diabetes mellitus blood glucose blood lipid SOD
  • 相关文献

参考文献6

二级参考文献64

  • 1徐济良,何敏,郑民,吴锋.Ⅱ型糖尿病大鼠不同病程期主动脉功能的改变[J].中国临床药理学与治疗学,2004,9(7):788-791. 被引量:3
  • 2杭悦宇.我国山药类药材对动物降血糖和降血脂的作用[J].植物资源与环境,1994,3(4):59-60. 被引量:28
  • 3Krentz AJ,Bailey CJ.Oral antidiabetic agents:current role in type 2diabetes mellitus.Drugs,2005,65(3):385-411.
  • 4Pereira AM,Biermasz NR,Roelfsema F,et al.A pharmacologic therapies for acromegaly:a review of their effects on glucose metabolism and insulin resistance.Treatments Endocrinol,2005,4(1):43-53.
  • 5Tenenbaum A,Motro M,Fisman EZ,et al.Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease.Circulation,2004,109(18):2197-2202.
  • 6Bergman RN.Non-esterified fatty acids and the liver.Why is insulin secreted into the portal vein? Diabetologia,2000,43:946-952.
  • 7Unger RH.Lipotoxic diseases.Annu Rev Med,2002,53:319-336.
  • 8Talpur N,Echard B,Ingram C,et al.Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats:a pilot study.Diabetes Obes Metab,2005,7(2):193-199.
  • 9Papaccio G,Latronico M,Frascatore S,et al.Superoxide dimutase in low-dose-streptozotin-treatedmice,a dynamic time course study[J].Int J$Pancreatol,1991,10:253.
  • 10Maxwell SR,Thomason H,Sandler D,et al.Poor glycaemic control is associated with reduced serum radical scavenging(antioxidant)activity in non-insulin-dependent diabetes mellitus[J].Ann Clin Biochem,1997,34(6):638.

共引文献281

同被引文献21

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部